Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05418153 · ClinicalTrials.gov registry record
Synergy Lens Outcomes Evaluation
A clinical trial of Presbyopia and Pseudophakia, sponsored by Center For Sight.
- Completed
- Registry status
- 52
- Enrollment target
- 2
- Study locations
NCT05418153: Completed study of Presbyopia and Pseudophakia, sponsored by Center For Sight.
NCT05418153 is a study of Presbyopia and Pseudophakia that has completed, run by Center For Sight. The registered enrollment target is 52 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05418153, a study of Presbyopia and Pseudophakia, has completed, sponsored by Center For Sight.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a single visit study to evaluate the visual outcomes and patient satisfaction of patients who were bilaterally implanted with the Tecnis Synergy IOL between June 1 and December 31, 2021 in 2 centers in USA
Primary Outcome
Visual acuity measured at 40 cm
Conditions Studied
Interventions
- DEVICE Tecnis Synergy IOL
Study Locations (2)
Florida
- Center For Sight - Venice
South Carolina
- Carolina Eyecare Physicians - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2022-11-22 |
What the finished NCT05418153 record still lists
NCT05418153 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 1 intervention - of which Tecnis Synergy IOL is the first listed.
NCT05418153 reports a single indexed study location in Florida, South Carolina.
Frequently Asked Questions
What is clinical trial NCT05418153 about?
NCT05418153 is a clinical study titled "Synergy Lens Outcomes Evaluation". This is a single visit study to evaluate the visual outcomes and patient satisfaction of patients who were bilaterally implanted with the Tecnis Synergy IOL between June 1 and December 31, 2021 in 2 centers in USA
What is the current status of trial NCT05418153?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2022-03-14. Estimated completion is 2022-11-22.
What conditions does trial NCT05418153 study?
This clinical trial studies the following conditions: Presbyopia, Pseudophakia.
What interventions are being tested in trial NCT05418153?
The interventions under investigation include: Tecnis Synergy IOL (DEVICE).
Who is sponsoring clinical trial NCT05418153?
This trial is sponsored by Center For Sight, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05418153 being conducted?
This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05418153's enrollment target sits among peer trials
52 26th of 38 higher than 13 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Comfort and Vision With TOTAL30 Multifocal Lenses
RECRUITING
-
North American Comfilcon A Clinical Study
RECRUITING
-
IC-8 Apthera IOL New Enrollment Post Approval Study
RECRUITING
-
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI